T lymphocyte-targeted immune checkpoint modulation in glioma

Immunomodulatory therapies targeting inhibitory checkpoint molecules have revolutionized the treatment of solid tumor malignancies. Concerns about whether systemic administration of an immune checkpoint inhibitor could impact primary brain tumors were answered with the observation of definitive resp...

Descripción completa

Detalles Bibliográficos
Autores principales: Kelly, William James, Giles, Amber Jin, Gilbert, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7057419/
https://www.ncbi.nlm.nih.gov/pubmed/32051289
http://dx.doi.org/10.1136/jitc-2019-000379

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7057419/
https://www.ncbi.nlm.nih.gov/pubmed/32051289
http://dx.doi.org/10.1136/jitc-2019-000379

Ejemplares similares